The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vancomycin, traditionally considered the ultimate treatment option for MRSA infections, has become less effective due to the evolution of resistance mechanisms [205,206].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [205]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 2×
“aureus (VISA) was identified in 1997, and these strains have now been reported worldwide [8,9].”
BackgroundAntimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095 · cited 3×
“aureus (VRSA), which is even more alarming, as these isolates demonstrate complete vancomycin resistance [11–14].”
BackgroundEmergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Methicillin-Resistant Staphylococcus aureus
Brumfitt, W., & Hamilton-Miller, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201806 · Cited by 934
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Cited by
A Review on Antibiotic Resistance: Alarm Bells are Ringing
Zaman, S. B., Hussain, M. A., Nye, R., Mehta, V., Mamun, K. T., & Hossain, N. (2017) · Cureus · doi:10.7759/cureus.1403 · Cited by 854
Roberts, R. R., Hota, B., Ahmad, I., Scott II, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L. M., Ciavarella, G. G., Supino, M., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/605630 · Cited by 705
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin
French, G. L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl393 · Cited by 441
The growing burden of antimicrobial resistance
Hawkey, P. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn241 · Cited by 377
Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies
Naber, C. K. (2009) · Clinical Infectious Diseases · doi:10.1086/598189 · Cited by 313
Relevance of microbial coculture fermentations in biotechnology
Bader, J., Mast‐Gerlach, E., Popović, M. K., Bajpai, R., & Stahl, U. (2010) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04659.x · Cited by 287
Penicillin‐binding protein 2a of methicillin‐resistant Staphylococcus aureus
Fishovitz, J., Hermoso, J. A., Chang, M., & Mobashery, S. (2014) · IUBMB Life · doi:10.1002/iub.1289 · Cited by 279
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
Schneider, T., & Sahl, H.-G. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.005 · Cited by 261
Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen
Top, J., Willems, R., & Bonten, M. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00383.x · Cited by 260
Adembri, C., Fallani, S., Cassetta, M. I., Arrigucci, S., Ottaviano, A., Pecile, P., Mazzei, T., De Gaudio, R., & Novelli, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.09.009 · Cited by 162
Werth, B. J., Vidaillac, C., Murray, K. P., Newton, K. L., Sakoulas, G., Nonejuie, P., Pogliano, J., & Rybak, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02354-12 · Cited by 69
Does Antibiotic Resistance Evolve in Hospitals?
Seigal, A., Mira, P., Sturmfels, B., & Barlow, M. (2017) · Bulletin of Mathematical Biology · doi:10.1007/s11538-016-0232-7 · Cited by 18
Metadata
- Authors
- Appelbaum, P. C.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2006
- Volume
- 12
- Pages
- 16-23
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1761182137
- Cited by
- 376
- References
- 35
- FWCI
- 21.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.